Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple Myeloma

Pasvolsky, O; Milton, DR; Rauf, M; Tanner, MR; Bashir, Q; Srour, S; Tang, GL; Saini, N; Ramdial, J; Masood, A; Nieto, Y; Lee, HC; Patel, KK; Kebriaei, P; Thomas, SK; Weber, DM; Orlowski, RZ; Shpall, EJ; Champlin, RE; Qazilbash, MH

Qazilbash, MH (通讯作者)，MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Box 423,1515 Holcombe Blvd, Houston, TX 77030 USA.

TRANSPLANTATION AND CELLULAR THERAPY, 2022; 28 (11):

Abstract

Maintenance therapy with single-agent lenalidomide (Len) after autologous hematopoietic stem cell transplantation (autoHCT) for multiple myeloma (MM) ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索